Efficacy and Safety of Celecoxib Versus Ibuprofen in the Treatment of Osteoarthritis of the Knee (United States)
Public ClinicalTrials.gov record NCT00620867. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Study of the Efficacy and Tolerability of Once Daily Celebrex (Celecoxib) and Three Times Daily Ibuprofen vs. Placebo in the Treatment of Subjects With Osteoarthritis of the Knee
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To compare the efficacy and safety of celecoxib versus ibuprofen in subjects with osteoarthritis (OA) of the knee.
Study identification
- NCT ID
- NCT00620867
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 393 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2002 (Type not available)
- Primary completion
- Mar 2003 (Actual)
- Completion
- Mar 2003 (Actual)
- Last update posted
- Feb 21, 2021
2002 – 2003
United States locations
- U.S. sites
- 33
- U.S. states
- 19
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Anniston | Alabama | 36207 | — |
| Pfizer Investigational Site | Phoenix | Arizona | 85051 | — |
| Pfizer Investigational Site | Anaheim | California | 92804 | — |
| Pfizer Investigational Site | Long Beach | California | 90806 | — |
| Pfizer Investigational Site | Paramount | California | 90723 | — |
| Pfizer Investigational Site | San Diego | California | 92108 | — |
| Pfizer Investigational Site | DeLand | Florida | 32720 | — |
| Pfizer Investigational Site | Miami | Florida | 33186 | — |
| Pfizer Investigational Site | Naples | Florida | 34102 | — |
| Pfizer Investigational Site | Pembroke Pines | Florida | 33024 | — |
| Pfizer Investigational Site | St. Petersburg | Florida | 33710 | — |
| Pfizer Investigational Site | Chicago | Illinois | 60610 | — |
| Pfizer Investigational Site | Evansville | Indiana | 47712 | — |
| Pfizer Investigational Site | Las Vegas | Nevada | 89102 | — |
| Pfizer Investigational Site | Edison | New Jersey | 08817 | — |
| Pfizer Investigational Site | South Plainfield | New Jersey | 07080 | — |
| Pfizer Investigational Site | Albuquerque | New Mexico | 87109 | — |
| Pfizer Investigational Site | Brooklyn | New York | 11203 | — |
| Pfizer Investigational Site | New York | New York | 10022-1009 | — |
| Pfizer Investigational Site | Cincinnati | Ohio | 45242 | — |
| Pfizer Investigational Site | Columbus | Ohio | 43124 | — |
| Pfizer Investigational Site | Tulsa | Oklahoma | 74136 | — |
| Pfizer Investigational Site | Altoona | Pennsylvania | 16601 | — |
| Pfizer Investigational Site | Jenkintown | Pennsylvania | 19046 | — |
| Pfizer Investigational Site | Newtown | Pennsylvania | 18940 | — |
| Pfizer Investigational Site | Warwick | Rhode Island | 02886 | — |
| Pfizer Investigational Site | Charleston | South Carolina | 29407 | — |
| Pfizer Investigational Site | Greer | South Carolina | 29651 | — |
| Pfizer Investigational Site | Mt. Pleasant | South Carolina | 29464 | — |
| Pfizer Investigational Site | Johnson City | Tennessee | 37601 | — |
| Pfizer Investigational Site | Dallas | Texas | 75235 | — |
| Pfizer Investigational Site | Layton | Utah | 84041 | — |
| Pfizer Investigational Site | Danville | Virginia | 24541 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00620867, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 21, 2021 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00620867 live on ClinicalTrials.gov.